Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 7, 2004, Pages 2576-2580

  Schmitt Hoffmann, Anne ^a   Nyman, Lars ^b   Roos, Brigitte ^a   Schleimer, Michael ^a   Sauer, Jill ^a   Nashed, Norman ^a   Brown, Thomas ^a   Man, Anthony ^a   Weidekamm, Erhard ^a  

^a BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

^b IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTOBIPROLE; CEFTOBIPROLE MEDOCARIL; CEPHALOSPORIN DERIVATIVE; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; EXTRACELLULAR SPACE; FATIGUE; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; NORMAL HUMAN; PHARMACOKINETICS; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; STEADY STATE; STREPTOCOCCUS PNEUMONIAE; TASTE DISORDER;

ADULT; AREA UNDER CURVE; CEPHALOSPORINS; CHROMATOGRAPHY, LIQUID; DOUBLE-BLIND METHOD; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT;

EID: 3042531426     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.7.2576-2580.2004     Document Type: Article

References (17)

1. Alexander, J., D. S. Bindra, J. D. Glass, M. A. Holahan, M. L. Renyer, G. S. Rork, et al. 1996. Investigation of (oxodioxolenyl) methyl carbamates as nonchiral bioreversible prodrug moieties for chiral amines. J. Med. Chem. 39:480-486.
2. Cars, O. 1997. Efficacy of beta-lactam antibiotics: integration of pharmacokinetics and pharmacodynamics. Diagn. Microbiol. Infect. Dis. 27:29-33.
3. Chew, T. A., and J. M. Smith. 1992. Detection of diacetyl (caramel odor) in presumptive identification of the "Streptococcus milleri" group. J. Clin. Microbiol. 30:3028-3029.
4. Craig, W. A. 2001. Does the dose matter? Clin. Infect. Dis. 33(Suppl. 2): 233-237.
5. Entenza, J. M., P. Hohl, I. Heinze-Krauss, M. P. Glauser, and P. Moreillon 2002. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Antimicob. Agents Chemother. 46:171-177.
6. Fuchs, P. C., A. L. Barry, and S. D. Brown. 2000. Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator. Antimicrob. Agents Chemother. 44:2880-2882.
7. Hebeisen, P., I. Heinze-Krauss, P. Angehrn, P. Hohl, M. G. P. Page, and R. L. Then. 2001. In vitro and in vivo properties of Ro 63-1941, a novel broad-spectrum cephalosporin with activity agains methicillin-resistant staphylococci. Antimicob. Agents Chemother. 45:825-836.
8. Jones, R. N., L. M. Deshpande, A. H. Mutnick, and D. J. Biedenbach. 2002. In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci. J. Antimicrob. Ther. 50:915-932.
9. Klepser, M. E., M. N. Marangos, K. B. Patel, D. P. Nicolau, R. Quintiliani, and C. H. Nightingale. 1995. Clinical pharmacokinetics of newer cephalosporins. Clin. Pharmacokinet. 28:361-384.
10. Mouton, J. W., and N. Punt. 2001. Use of the t>MIC to choose between different dosing regimens of beta-lactam antibiotics. J. Antimicrob. Chemother. 47:500-501.
11. Nix, D., S. Goodwin, C. Peloquin, D. Rotella, and J. Schentag. 1991. Antibiotic tissue distribution and its relevance: models of tissue penetration and their meaning. Antimicrob. Agents Chemother. 35:1947-1952.
12. National Nosocomial Infections Surveillance System. 2001. NNIS special article. National Nosocomial Infections Surveillance System Report, data summary from January 1992-June 2001, issued August 2001. Am. J. Infect. Control 29:404-421.
13. Rogerson, F. S., H. Castro, N. Fortunato, Z. Azevedo, A. Macedo, and V. A. De Freitas. 2001. Chemicals with sweet aroma descriptors found in Portuguese wines from the Douro region: 2,6,6-trimethylcyclohex-2-ene-1,4-dione and diacetyl. J. Agric. Food Chem. 49:263-269.
14. Schmitt-Hoffmann, A., B. Roos, M. Schleimer, J. Sauer, A. Man, N. Nashed, T. Brown, A. Perez, E. Weidekamm, and P. Kovács. 2004. Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers. Antimicob. Agents Chemother. 48:2570-2575.
15. Sievert, D. M., M. L. Boulton, G. Stoltman, D. Johnson, M. G. Stobierski, F. P. Downes, P. A. Somsel, J. T. Rudrik, W. Brown, W. Hafeez, T. Lundstrom, E. Flanagan, R. Johnson, J. Mitchell, and S. Chang. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb. Mortal. Wkly. Rep. 51:565-567.
16. Sörgel, F., and M. Kinzig. 1993. The chemistry, pharmacokinetics and tissue distribution of piperazillin/tazobactam. J. Antimicrob. Chemother. 31:39-60.
17. Tsiodras, S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, R. C. Moellering, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208.